Home Stock

Stock Research: Johnson & Johnson

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Johnson & Johnson

NYQ:JNJ US4781601046
55
  • Value
    71
  • Growth
    63
  • Safety
    Safety
    44
  • Combined
    62
  • Sentiment
    43
  • 360° View
    360° View
    55
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Johnson & Johnson researches, develops, manufactures, and sells healthcare products. It operates in the healthcare field through two segments: Innovative Medicine and MedTech. Medicines are distributed worldwide. In the last fiscal year, the company had a market cap of $373,350 million, profits of $61,385 million, revenue of $88,821 million, and 138,100 employees.

more

ANALYSIS: With an Obermatt 360° View of 55 (better than 55% compared with alternatives), overall professional sentiment and financial characteristics for the stock Johnson & Johnson are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Johnson & Johnson. The consolidated Value Rank has an attractive rank of 71, which means that the share price of Johnson & Johnson is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 71% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 63, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 43. Professional investors are more confident in 57% other stocks. Worryingly, the company has risky financing, with a Safety rank of 44. This means 56% of comparable companies have a safer financing structure than Johnson & Johnson. ...read more

more
Strongest Rank Price vs. Earnings (P/E)
Weakest Rank Profit Growth
Country USA
Industry Pharmaceuticals
Size Medium
Website jnj.com
Index
Dow Jones
D.J. US Health Care
D.J. US Pharmaceutical
S&P 500
Johnson & Johnson stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 17-Sep-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
71 51 60 65
Growth
63 41 25 51
Safety
Safety
44 56 73 72
Sentiment
43 54 10 75
360° View
360° View
55 43 27 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
25 26 17 38
Opinions Change
50 50 6 66
Pro Holdings
n/a 94 76 36
Market Pulse
43 37 26 86
Sentiment
43 54 10 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
71 51 60 65
Growth
63 41 25 51
Safety Safety
44 56 73 72
Combined
62 45 56 80
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
47 24 20 20
Price vs. Earnings (P/E)
18 48 54 58
Price vs. Book (P/B)
34 12 18 20
Dividend Yield
93 94 96 96
Value
71 51 60 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
49 33 34 27
Profit Growth
98 35 46 66
Capital Growth
18 58 23 42
Stock Returns
67 51 49 75
Growth
63 41 25 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
30 51 55 67
Refinancing
39 12 21 13
Liquidity
84 96 98 96
Safety Safety
44 56 73 72

Similar Stocks

Discover high‑ranked alternatives to Johnson & Johnson and broaden your portfolio horizons.

Microsoft

NSQ:MSFT
Country: USA
Industry: Systems Software
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Nexstar

NSQ:NXST
Country: USA
Industry: Broadcasting
Size: X-Large
Full Stock Analysis

Toll Brothers

NYQ:TOL
Country: USA
Industry: Homebuilding
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a mixed bag with good value and high growth balanced by risky financing and negative sentiment. This is a risky stock that requires conviction; you should only consider it if you are willing to conduct further research into the underlying sentiment and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews